Timo Minssen (Former)

11 – 20 of 103

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/20de8c98-a729-4851-afed-37a4f8eb946d?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
11
next »

2020
Mark Denmark
Minssen, Timo ^LU ; Goldschmieding, Tue and Sandfeld Jakobsen, Søren (2020) p.113-128
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
Kianzad, Behrang ^LU and Minssen, Timo ^LU (2020)
- Other contribution › Miscellaneous
Mark The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?
Minssen, Timo ^LU ; Seitz, Claudia ; Aboy, Mateo and Corrales Compagnucci, Marcelo (2020) In European Pharmaceutical Law Review 4(1). p.34-50
- Contribution to journal › Article
Mark Establishing the First International Genetic Discrimination Observatory
Joly, Yann ; Dalpe, Gratien ; Minssen, Timo ^LU ; Ó Cathaoir, Katharina ; De Paor, Aisling ; Granados Moreno, Palmira ; Dove, Edward ; van Hoyweghen, Ine ; Ho, Chih-hsing and Ho, Calvin WL , et al. (2020) In Nature Genetics 52. p.466-468
- Contribution to journal › Article
Mark One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen ; Davey, Neil ; Liddicoat, Johnathon and Minssen, Timo ^LU (2020) In Nature Biotechnology 38(3). p.279-283
- Contribution to journal › Article
Mark Preparing for antimicrobial resistance in the wake of the COVID-19 pandemic: The vision and “social science” mission of the INAMRSS network
Minssen, Timo ^LU ; Outterson, Kevin ; Van Katwyk, Susan Rogers ; Batista, Pedro Henrique D. ; Chandler, Clare ; Ciabuschi, Francesco ; Harbarth, Stephan ; Kesselheim, Aaron ; Laxminarayan, Ramanan and Liddell, Kathleen , et al. (2020)
- Other contribution › Web publication
Mark Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield
Corrales Compagnucci, Marcelo ; Minssen, Timo ^LU ; Seitz, Claudia and Aboy, Mateo (2020) In European Pharmaceutical Law Review 4(3). p.153-160
- Contribution to journal › Article
Mark A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
Druedahl, Louise C. ; Almarsdóttir, Anna Birna ; Sporrong, Sofia Kälvemark ; Bruin, Marie Louise De ; Hoogland, Hans ; Minssen, Timo ^LU ; Weert, Marco van de ; Kesselheim, Aaron S. and Sarpatwari, Ameet (2020) In Nature Biotechnology 38(11). p.1253-1256
- Contribution to journal › Article
Mark ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19
Druedahl, Louise C. ; Lebret, Audrey and Minssen, Timo ^LU (2020) In Journal of Law, Medicine & Ethics 48(3). p.579-582
- Contribution to journal › Article
Mark An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014
de Miguel Beriain, Iñigo ; Chortara, Theodora ; Duardo-Sánchez, Aliuska ; Feeney, Oliver ; Felzmann, Heike ; Fernández de Uzquiano, Emma ; Lievevrouw, Elisa ; Marelli, Luca ; Mattsson, Titti ^LU and Rothmar Herrmann, Janne , et al. (2020) In European Public Law 26(2). p.307-330
- Contribution to journal › Article

« previous
1
2
3
4
5
…
11
next »